• 대한화학회지
• /
• 제53권3호
• /
• pp.340-344
• /
• 2009

Phosphonitrillic chroride cyclic trimer 화합물을 $200{\sim}300\;{^{\circ}C}$ 하에 개환중합하여 선상 고분자를 얻 은 후 Grignard 시약 ($CH_2$=CH-MgBr)을 천천히 가하여 vinyl 기를 포함하는 polyphosphazene을 합성하였 으며, 이 폴리머를 HEMA(2-hydroxyethyl methacrylate)와 반응시켜 HEMA/vinyl-substituted polyphosphazene 을 얻었다. 이 고분자를 AIBN (azobisisobutyronitrile) 개시제 존재 하에서 교차결합제로 EGDMA(ethylene glycol dimethacrylate) 그리고 NVP (N-vinyl-pyrrolidone)을 혼합하여 공중합 시켰다. 얻어진 공중합체에 대한 측정 결과 산소투과율 (Dk/t)은 88로 측정되었으며, 함수율은 30.89% 그리고 가시광선 투과율은 87%로 나타났다. 이 자료로부터 이 공중합체가 우수한 콘택트렌즈 재료임을 발견하였다.

• Macromolecular Research
• /
• 제17권7호
• /
• pp.522-527
• /
• 2009

A photocrosslinkable polyphosphazene was used for molecular imprinting. We synthesized polyphosphazene (3) having urea groups for complexation with N-carbobenzyloxyglycin (Z-Gly-OH, template) and chalcone groups for cross-linking reaction. As substituents, 4-hydroxycha1cone (1) and N-(4-hydroxyphenyl)-N'-ethylurea (2) were prepared. Choloro groups of poly(dichlorophosphazene) were replaced by the sequential treatment with sodium salts of compounds 1 and 2, and trifluoroethanol. The template molecule was complexed with the urea groups on the polymer chains via hydrogen bonding. A thin polymer film was prepared by casting a solution of the complex of polymer 3 and the template in dimethylformamide on a quartz cell and irradiated with 365 nm UV light to yield a cross-linked film with a thickness of about $16{\mu}m$. The template molecules in the film were removed by Soxhlet extraction with methanol/acetic acid. The control polymer film was prepared in the same manner for the preparation of the imprinted polymer film, except that the template and triethylamine were omitted. In the rebinding test, the imprinted film exhibited much higher recognition ability for the template than the control polymer. We also investigated the specific recognition ability of the imprinted polymer for the template and its structural analogues. The rebinding tests were conducted using Z-Glu-OH, Z-Asp($O^tBu$)-OH, and Z-Glu-OMe. The imprinted film showed higher specific recognition ability for the template and the lowest response for Z-Asp($O^tBu$)-OH.

• 멤브레인
• /
• 제21권4호
• /
• pp.329-335
• /
• 2011

당뇨병 환자의 혈당치 측정을 위하여 메톡시에톡시기와 트라이플루오르에톡시기가 함께 치환된 포스파젠 고분자를 기초로 한 새로운 형태의 진단막을 제조하였다. 플라즈마와 혈액속의 글루코우즈의 농도를 변화시켜가며 활성화 된 폴리포스파젠 진단막을 가지고 680 nm에서의 최종흡광도를 측정하였다. 시간에 따른 흡광도 변화량(K/S)의 최종 결과치가 글루코우즈의 농도가 증가함에 따라 직선적으로 증가하였다. 친수성기와 소수성기의 치환율이 글루코우즈의 농도 측정에 미치는 영향을 조사하였다. 친수성기의 치환율이 증가함에 따라 글루코우즈의 농도와 K/S와의 기울기 값(Dose-Response Slope : DRS)이 점차 증가하였다. 그러나 친수성기의 치환율이 30% 이상일 경우에는 DRS가 급격히 증가하여 정확한 글루코우즈의 농도 측정이 어려웠다.

• 폴리머
• /
• 제35권5호
• /
• pp.424-430
• /
• 2011

Biodegradable poly[(glycine ethyl ester)-(phenylalanine ethyl ester) phosphazene](PGPP) microparticles were fabricated by electrohydrodynamic atomization to apply drug release test. Atomization parameters such as applied voltage, polymer concentration, and molecular weight were investigated to inspect their effects on the size and morphology of microparticles. The average diameter of PGPP microparticles decreased as increasing applied voltage and solution flow rate. Dichloromethane/dioxane mixture shows better results for the preparation of microparticles than single solvent owing to the different PGPP solubility in solvent. Blending PGPP polymers with proper molecular weights not only favored the production of spherical PGPP microparticles via electrohydrodynamic atomization, but also provided a way to adjust drug (rifampicin) release behavior. Drug-loaded biodegradable polyphosphazene microspheres can be fabricated via electrohydrodynamic atomization, which has potential use in biomedical applications.

• 공업화학
• /
• 제5권2호
• /
• pp.321-326
• /
• 1994

에테르기를 가진 수용성 포스파젠 고분자를 감마광선에 노출시켜 좋은 수분-팽윤도를 가진 친수성 겔을 만들었다. 이 친수성 겔들의 물리적 강도가 감마광선의 강도에 따라 조절될 수 있었다. 트립신과 수용성 포스파젠 고분자를 함께 감마광선에 쪼여 트립신을 겔의 망 사이로 고정시켰다. 고정된 트립신의 활성도는 N-${\alpha}$-benzoyl-1-arginine-p-nitroanilide와 반응시킨 후 분광학적인 방법으로 조사하였다. 고정된 트립신은 적어도 500시간 후에도 상당히 좋은 활성도 수율과 안정도를 가지고 있었음을 보여주었다.

• 대한약학회:학술대회논문집
• /
• 대한약학회 2005년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2
• /
• pp.152-153
• /
• 2005

• 공업화학
• /
• 제5권5호
• /
• pp.843-850
• /
• 1994

$[NP(OC_6H_5)_{1.7}(OC_6H_4P(Ph)_2$=$CHCH_2CH_2CH_3)_{0.3}]_n$과 같은 포스파젠 고분자에 부착된 Wittig 시약을 $[NP(OC_6H_5)_{1.7}(OC_6H_4Br)_{0.3}]_n$에 n-butyllithium, diphenylchlorophosphine, 그리고 n-butyl iodide 등으로 처리하여 만들었다. 고분자의 반응들은 [$NP(OC_6H_5)_5(OC_6H_4P(Ph)_2$)]와 같은 고리형 삼중체를 이용한 모델반응 조건들을 고려해 이루어졌다. 포스파젠 고분자에 부착된 Wittig 시약과 benzophenone을 반응시켜 원하는 알켄과 고분자에 부착된 phosphine oxide를 성공적으로 만들었다.

• Journal of Pharmaceutical Investigation
• /
• 제25권2호
• /
• pp.117-123
• /
• 1995

For the effective administration of narcotic antagonist, the application of sustained release implantable systems with biodegradable polyphosphazene was examined. Using poly[(diethyl glutamate)-co-(ethyl glycinate) phosphazene], the implantable devices containing naloxone hydrochloride were prepared and in vivo implantation studies were carried out subcutaneously in rat and rabbit with this preparation for the biocompatibility and pharmacokinetics. The histological finding in rats at initial time period was the inflammation that occurred focally around the implants, but they were showed subsequent mild and limited chronic inflammations and the irreversible changes such as necrosis and degeneration of the muscle or connective tissues were not observed. Therefore the placebo and naloxone implants are considered to be biocompatible formulations histologically. In pharmacokinetic studies, the release of naloxone from the naloxone implants into blood plasma was maintained in 192 hours, but the initial burst effect was observed. If this problem was solved, the application for the narcotic antagonist sustained release systems can be expected.

• Journal of Pharmaceutical Investigation
• /
• 제27권3호
• /
• pp.225-231
• /
• 1997

For the effective administration of naloxone, we attempted to investigate the naloxone sustained-release implants. Using the biodegradable polymer, poly[(diethyl glutamate)-co-(ethyl glycinate)phosphazenes](PGGP), the implantable devices containing naloxone hydrochloride(NLX HCl) and naloxone base(NLX) were prepared. The release rates of NLX and NLX HCl were compared. Influences of NLX contents on release rates were examined. For pharmacokinetic studies, NLX and NLX HCl loaded devices were implanted subcutaneously in rabbits and then the plasma concentrations of NLX were determined by HPLC(ECD). NLX-containing devices were implanted with various doses and pharmacokinetic parameters according to dose were calculated. The relative bioavailabilities were evaluated and compared. Incorporation of NLX in the polymer leaded to a slow release. There were no differences of release rates based on drug contents. In pharmacokinetic parameters determined in 216 hours, NLX loaded devices resulted in enhanced bioavailability with the higher AUC (p<0.01) than NLX HCl loaded devices and MRT was significantly (p<0.05) increased. This result demonstrates that NLX is more suitable for sustained release devices than NLX HCl. Therefore it is anticipated that the effective concentrations of naloxone could be maintained for longer periods and bioavailabilities could be improved by naloxone sustained-release implants, with varying drug base/hydrochloride.

• Journal of Pharmaceutical Investigation
• /
• 제25권2호
• /
• pp.109-116
• /
• 1995

For the administration of narcotic antagonist with short half-life and low patient compliance, the sustained release system using biodegradable matrix is effective. Polyphosphazenes are of considerable interest as biodegradable matrix systems for controlled release of drugs. In this study, biodegradable polyphosphazenes available for the sustained release implantable device were synthesized, and their application was examined. Poly[dichlorophosphazene] was synthesized by solution polymerization method and confirmed with IR spectrum. Poly[bis(ethyl glycinate) phosphazene] and poly[ (diethyl glutamate)-co-(ethyl glycinate)phosphazene] were then produced by substitution of amino acid alkyl esters for chloride side groups. Using these polymers, the implantable devices of 1 mm thickness and $10{\times}10\;mm$ size containing naloxone hydrochloride were prepared and their release and degradation profiles were measured. In the case of poly[bis(ethyl glycinate)phosphazene] with swelling characteristics, degradation rate was slower than the release rate, showing that the release rate is partly dependent on the swelling rate. In contrast, the degradation rate of polyl[(diethyl glutamate)-co-(ethyl glycinate)phosphazene] matrix was identical with release rate of naloxone hydrochloride. On the basis of these results, it is expected that these polymers can be applied to sustained release implantable systems delivering narcotic antagonist.